$ATI

ATI Inc (ATI) Shares Fall 10.4% -- What GF Score of 69 Tells Inv

ATI Inc (ATI) shares fell 10.4% to $161.84 on October 22, 2026, within its 52-week range of $83.15 to $243.57. The GF Value™ estimates the stock as significantly overvalued, with a 103.4% premium over its intrinsic value of $79.57. ATI's GF Score™ is 69/100, indicating above-average performance. Insiders sold $82.6M in shares over the past year, with no buying activity. The P/E ratio is 47.3x, higher than its 5-year median of 24.3x.

Original reporting
Published Oct 23, 2026, 12:04 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 23, 2026, 12:45 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
$ATI
Bearish
medium confidence
Mentioned
$ATI
Relevance
5/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$ATIBearishLow
01

Why it matters

The price decline reflects market skepticism about the stock's high valuation relative to its intrinsic value.

02

Market read

The article signals a bearish outlook for ATI due to overvaluation and insider selling.

03

What to watch

Potential upcoming product launches or contract wins not covered in the article could offset valuation concerns.

Relevance 5/10Novelty 3/10Timing: today

Background

GuruFocus valuation analysis reports ATI Inc shares falling sharply amid high P/E and insider sell‑off.

Company-level read

Ticker impact

$ATIBearishMedium confidence
Context

Shares fell 10.4% to $161.84 on Oct 22, 2026, indicating a sharp price decline.

Expected impact

likely downward pressure as overvaluation concerns persist

Evidence & confidence

The article highlights a 10%+ price drop, a GF valuation gap of 103% above intrinsic value, and $82.6M of insider sales, all suggesting continued downside risk.

Market effects

Valuation concerns may affect peers in the same industrial segment.

Primarily U.S. market impact as ATI is a U.S.-listed stock.

Limited to investors tracking overvalued stocks and insider activity.

Counterpoint

If the market overreacts, the price could stabilize and attract value-oriented buyers.

Key entities

  • ATI Inc

    U.S.-listed industrial company whose shares fell 10.4%.

Related articles

$ATIMed

How Investors Are Reacting To ATI (ATI) Record Backlog And Raised Guidance

ATI Inc. raised its 2026 adjusted EBITDA and free cash flow guidance, citing record backlog and strong aerospace and defense demand. The company's updated outlook includes high teens defense growth, reinforcing its long-cycle thesis. ATI's share price is up 64% year-to-date, outpacing its industry group. Key risks include execution challenges and softer demand in industrial and medical sectors.

$ATIMed

ATI Shares Surge 64% YTD: What's Driving the Momentum?

ATI Inc. shares have surged 64% year to date, outperforming the aerospace-defense industry and S&P 500. The company reports strong aerospace and defense demand, a record backlog, and improved profitability. Q2 2026 jet-engine revenue rose 13%, defense sales increased 36% to $162M, and adjusted EBITDA grew 37% to $284.4M. ATI raised its 2026 adjusted EBITDA outlook to $1.135-$1.185B and adjusted free cash flow guidance to $550-$600M.

$ATIMed

4 Top Aerospace & Defense Stocks to Consider as America Commemorates 9/11

Four aerospace and defense stocks (ATI, DCO, IA, LOAR) are highlighted as Strong Buys by Zacks, with strong Q2 earnings and raised guidance. ATI reported $1.26B in sales (+10% YoY), record backlog of $4.4B, and raised 2026 EPS guidance. DCO saw record revenue of $224.5M (+11% YoY) and adjusted EPS of $1.18 (+34% YoY). IA reported $26.7M in sales (+11% YoY) and doubled adjusted EPS to $0.33. LOAR posted $171.6M in sales (+39% YoY) and raised 2026 EPS outlook.

$ATIMed

Extended Strategic Agreements to Support Management’s Full-Year 2026 Guidance Raise for ATI Inc. (ATI)

ATI Inc. (NYSE:ATI) raised its 2026 guidance after Q2 revenue rose 11% YoY to $1.26B, with adjusted EBITDA at $284.4M. The company secured long-term supply deals with BWX Technologies and Boeing, supporting its bullish outlook. However, risks include customer concentration and raw material cost volatility. Analysts remain bullish, with a consensus target price of $255.

$ATIMedAI 9/10

ATI’s (ATI) Record Backlog And Raised Guidance Signal Bigger Ambitions

ATI Inc. (NYSE:ATI) reported Q2 sales of $1.26B, up 11% YoY, with net income rising 50% to $151M. The company raised its full-year 2026 outlook, citing strong demand in aerospace and defense. ATI's backlog reached a record $4.4B, up 18% YoY. CEO Kimberly Fields noted demand outpacing supply, and the company repurchased $50M in shares. However, margins in one segment slipped, and debt increased to fund growth.

$ATIMed

Here's How Much a $1000 Investment in ATI Made 10 Years Ago Would Be Worth Today

ATI Inc., a Pittsburgh-based specialty materials producer, restructured in 2013 and 2020, focusing on High-Performance Materials & Components and Advanced Alloys & Solutions. In Q1 2026, earnings beat estimates but revenues missed. The company benefits from aerospace and defense demand but faces risks from production ramps and supply-chain issues.